Treasury Chief Rachel Reeves Aims for Focused Measures on Bills in Forthcoming Financial Plan
Chancellor Reeves has revealed she is preparing "specific measures to address cost of living challenges" in the upcoming Budget.
During an interview with the BBC, she noted that curbing price rises is a collective duty of both the government and the central bank.
The United Kingdom's price growth is projected to be the most elevated among the G7 industrialized countries this calendar year and next.
Possible Energy Bill Interventions
Reports indicate the government could intervene to bring down energy bills, for example by cutting the present 5% rate of VAT charged on energy.
Another option is to cut some of the regulatory levies currently included in bills.
Budgetary Limitations and Expert Expectations
The administration will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for these measures.
The consensus from most economists is that Reeves will have to introduce tax rises or expenditure reductions in order to adhere to her declared debt limits.
Previously on the same day, estimates suggested there was a twenty-two billion pound gap for the chancellor to address, which is at the more modest range of projections.
"There's a collective task between the Bank of England and the administration to continue tackling some of the sources of price increases," Reeves stated to reporters in the US capital, at the annual meetings of the International Monetary Fund and World Bank.
Tax Commitments and International Issues
While much of the attention has been on likely tax increases, the Treasury chief said the most recent data from the fiscal watchdog had not changed her vow to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.
She blamed an "uncertain world" with growing international and commercial issues for the fiscal tax moves, likely to be targeted on those "wealthiest."
International Economic Tensions
Commenting on concerns about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always are paramount."
Recent statement by China to increase trade restrictions on critical minerals and other resources that are essential for advanced tech production led US President Donald Trump to threaten an further 100% tariff on goods from China, increasing the possibility of an all-out commercial conflict between the two global powers.
The American finance chief labeled the Chinese decision "commercial pressure" and "a international production power grab."
Asked about considering the US offer to participate in its battle with China, the Chancellor said she was "deeply worried" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."
She said the move was "damaging for the world economy and generates additional headwinds."
"I believe there are fields where we must address China, but there are also valuable prospects to sell into Chinese markets, including financial services and other areas of the economic system. We've got to maintain that balance right."
The chancellor also stated she was cooperating with international partners "on our own essential resources plan, so that we are more independent."
Health Service Medicine Pricing and Funding
The Chancellor also recognized that the cost the NHS spends on pharmaceuticals could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.
Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping projects in the UK, with some blaming the low prices they are getting.
Last month, the government science advisor said the price the NHS pays for drugs would need to increase to halt companies and drug research funding departing from the United Kingdom.
Reeves informed the BBC: "We have seen due to the payment system, that clinical trials, new drugs have not been available in the United Kingdom in the way that they are in other EU nations."
"The objective is to guarantee that patients getting care from the NHS are can access the best essential drugs in the world. And so we are reviewing these issues, and... aiming to obtain more investment into Britain."